| Maturation of the angiotensin II cardiovascular response in the embryonic White Leghorn chicken (Gallus gallus). | |
| | |
MedLine Citation:
|
PMID: 20495810 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Angiotensin II (Ang II) is an important regulator of cardiovascular function in adult vertebrates. Although its role in regulating the adult system has been extensively investigated, the cardiovascular response to Ang II in embryonic vertebrates is relatively unknown. We investigated the potential of Ang II as a regulator of cardiovascular function in embryonic chickens, which lack central nervous system control of cardiovascular function throughout the majority of incubation. The cardiovascular response to Ang II in embryonic chickens was investigated over the final 50% of their development. Ang II produced a dose-dependent increase in arterial pressure on each day of development studied, and the response increased in intensity as development progressed. The Ang II type-1 receptor nonspecific competitive peptide antagonist [Sar(1) ile(8)] Ang II blocked the cardiovascular response to subsequent injections of Ang II on day 21 only. The embryonic pressure response to Ang II (hypertension only) differed from that of adult chickens, in which initial hypotension is followed by hypertension. The constant level of gene expression for the Ang II receptor, in conjunction with an increasing pressure response to the peptide, suggests that two Ang II receptor subtypes are present during chicken development. Collectively, the data indicate that Ang II plays an important role in the cardiovascular development of chickens; however, its role in maintaining basal function requires further study. |
| | |
Authors:
|
Dane A Crossley; Sonnet S Jonker; James W Hicks; Kent L Thornburg |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. Date: 2010-05-22 |
Journal Detail:
|
Title: Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology Volume: 180 ISSN: 1432-136X ISO Abbreviation: J. Comp. Physiol. B, Biochem. Syst. Environ. Physiol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-16 Completed Date: 2011-01-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8413200 Medline TA: J Comp Physiol B Country: Germany |
Other Details:
|
Languages: eng Pagination: 1057-65 Citation Subset: IM |
Affiliation:
|
Department of Biology, University of North Dakota, 10 Cornell Street, Mail stop 9019, Grand Forks, ND 58202, USA. dane.crossley@und.nodak.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
1-Sarcosine-8-Isoleucine Angiotensin II
/
pharmacology Angiotensin II / antagonists & inhibitors, blood, pharmacology, physiology* Angiotensin II Type 1 Receptor Blockers / pharmacology Animals Blood Pressure / drug effects, physiology Cardiovascular System / drug effects, embryology* Chick Embryo Chorioallantoic Membrane / drug effects, metabolism Dose-Response Relationship, Drug Embryonic Development / physiology* Gene Expression Regulation, Developmental / drug effects Heart / drug effects, embryology Heart Rate / drug effects, physiology Myocardium / metabolism RNA, Messenger / metabolism Receptor, Angiotensin, Type 1 / genetics, metabolism* Renin-Angiotensin System / drug effects, physiology* Reverse Transcriptase Polymerase Chain Reaction Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
2P01HD34430/HD/NICHD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/RNA, Messenger; 0/Receptor, Angiotensin, Type 1; 11128-99-7/Angiotensin II; 9088-01-1/1-Sarcosine-8-Isoleucine Angiotensin II |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Unexplained loss of visual acuity in a 22-year-old woman].
Next Document: Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with ...